Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

79 results about "Ginsenoside CK" patented technology

Compound enzyme for efficiently converting high-purity rare ginsenoside CK as well as preparation method and application of compound enzyme

ActiveCN119120431Aincrease vitalityImprove the efficiency of conversion into ginsenoside CKHydrolasesTransferasesGinsenoside CKAlglucerase
The invention relates to a compound enzyme for efficiently converting high-purity rare ginsenoside CK as well as a preparation method and application of the compound enzyme, and belongs to the technical field of microorganisms. The compound enzyme disclosed by the invention comprises beta-glucosidase, fructosyl transferase, lactase, cellulase and beta-glucanase. The beta-glucosidase, the fructosyl transferase, the lactase, the cellulase and the beta-glucanase are selected and matched to obtain the compound enzyme, the ginsenoside CK can be prepared in an enzyme engineering process, and the compound enzyme has the effect of improving the conversion rate of converting the ginsenoside Rb1 into the ginsenoside CK through synergistic interaction.
Owner:GUANGZHOU FANZHIRONG COSMETICS CO LTD +1

Anti-tumor medicine composition combined with PARG inhibitor and application

The invention discloses an anti-tumor medicine composition combined with a PARG inhibitor and application. Through natural product library screening and CCK-8 experiments, it is found that PARG knockout gastric cancer cells show significantly enhanced sensitivity to ginsenoside CK. Further clone formation experimental analysis shows that PARG knockout significantly enhances the inhibitory effect of ginsenoside CK on gastric cancer cell proliferation. In in-vivo experiments, a CDX model is utilized to verify that PARG knockout can significantly enhance the anti-tumor activity of ginsenoside CK on gastric cancer. The discovery provides an important experimental basis for clinical application of PARG as a gastric cancer treatment target and ginsenoside CK as a potential treatment drug. The research finds that the PARG inhibitor and ginsenoside CK are combined to achieve a better killing effect on other various cancer cells, and it is indicated that improvement of the effect is broad-spectrum.
Owner:HANGZHOU INSTITUTE OF MEDICAL SCIENCES CHINESE ACADEMY OF SCIENCES

Application of ginsenoside CK in preparation of product for reducing TMAO and / or TMA content

The invention discloses an application of ginsenoside CK in preparation of a product for reducing the content of TMAO and / or TMA. The ginsenoside CK can regulate and control generation of intestinal flora TMA and / or TMAO, and a theoretical basis is provided for follow-up treatment of TMAO related diseases through GCK.
Owner:CHANGSHA DUXACT BIOTECH CO LTD

Preparation method and application of high-purity rare ginsenoside CK

The invention belongs to the technical field of active substance preparation, and particularly relates to a preparation method and application of high-purity rare ginsenoside CK. The high-purity rare ginsenoside CK with the content exceeding 95% is finally produced through the steps of combined enzymolysis, ultrafiltration, nanofiltration, multiple crystallization and the like, the production efficiency and purity of the rare ginsenoside CK are improved through the preparation method, only ethyl alcohol and water are used as solvents in the whole process, it is guaranteed that the technology is green and environmentally friendly, and the method is suitable for industrial production. The method has the advantages of simple operation, no use of harmful chemical solvents, great reduction of environmental pollution, realization of the significant cost advantage in the whole production process due to repeated use of equipment and solvents, suitableness for large-scale industrial application, and wide market prospects and economic benefits.
Owner:GUANGZHOU QINGNANG BIOTECHNOLOGY CO LTD +1

Quick-dissolving microneedle patch capable of improving male hormonal alopecia as well as preparation method and application of quick-dissolving microneedle patch

The invention discloses a quick-dissolving microneedle patch capable of improving androgenetic alopecia. The needle tip part of the microneedle patch is coated with liposome nanoparticles loaded with ginsenoside CK and nitrosoglutathione GSNO. In addition, the invention also discloses a preparation method and application of the microneedle patch. The needle tip part of the microneedle patch can reach tissue interstitial fluid, ginsenosides CK and GSNO are slowly released after rapid dissolution to reach the microenvironment where hair papilla cells are located to play a role, the hair follicle microenvironment can be improved, and the activity of the hair papilla cells playing a key role in male hormonal alopecia is improved.
Owner:NORTHWEST UNIV

Construction method and application of tobacco plant for expressing rare ginsenoside

The invention belongs to the technical field of biology, and particularly relates to a construction method and application of a tobacco plant for expressing rare ginsenoside. According to the method, dammarendiol synthase DDS, cytochrome P450 CYP716A47 and glycosyl transferase UGTPg1 / UGTPg45 are added into tobacco, heterologous synthesis of rare ginsenosides CK and Rh2 is achieved, dependence on traditional ginseng cultivation extraction is avoided, and cost is remarkably reduced and efficiency is remarkably improved. The characteristics of short growth cycle and easy culture of tobacco are utilized to overcome the problems of low efficiency and low yield of traditional synthesis; positive transgenic tobacco leaves are dedifferentiated to form callus cells, so that materials are provided for large-scale fermentation, and an industrial production foundation is laid.
Owner:BEIJING LIFE SCIENCE ACADEMY CO LTD

Beta-glucosidase mutant with high catalytic activity and application thereof

The invention relates to the technical field of gene engineering and enzyme engineering, in particular to a beta-glucosidase mutant with high catalytic activity and application of the beta-glucosidase mutant. The sequence of the beta-glucosidase mutant is obtained by carrying out any one of the following mutations on an amino acid sequence as shown in SEQ ID No.1: respectively mutating proline at the 95th site and arginine at the 178th site into cysteine; phenylalanine at the 98th site and arginine at the 178th site are respectively mutated into cysteine. The obtained mutants P95C / R178C and F98C / R178C have high enzyme activity, ginsenoside Rb1 can be converted into CK, the conversion efficiency is respectively improved by 83.52% and 105.79% compared with that of wild beta-glucosidase, and the industrial application of enzymatic conversion of rare ginsenoside CK is promoted.
Owner:SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE

Screening and application of pseudomonas transcriptional regulation protein TtgR mutant

PendingCN119019517AEnable visualization of highly specific responsesEnsure accurate quantitationBacteriaMicroorganism based processesGinsenoside CKMicrobiology
The invention discloses screening and application of a pseudomonas transcriptional regulation protein TtgR mutant, and belongs to the technical field of genetic engineering. A special biosensor is constructed by modifying a pseudomonas transcriptional regulation protein TtgR and combining with a fluorescence reporter gene, and highly specific response to rare ginsenoside CK is realized. The specificity not only improves the high-yield screening efficiency of ginsenoside CK, but also ensures accurate quantification and extraction of a target product, and lays a solid foundation for subsequent application and research.
Owner:深圳智微生物科技有限公司

Ginsenoside nano-micelle based on intermolecular self-assembly as well as preparation method and application of ginsenoside nano-micelle

The invention relates to a ginsenoside nano-micelle based on intermolecular self-assembly as well as a preparation method and application thereof, and belongs to the technical field of nano-micelles. The preparation process of the ginsenoside nano-micelle comprises the following steps: converting raw materials of panaxadiol saponin by using a compound enzyme, removing impurities by passing through a column, carrying out intermolecular self-assembly under ultrasonic, and purifying; the ginsenoside nano-micelle is prepared from ginsenoside Rg5, ginsenoside CK and ginsenoside Rg3, and the ginsenoside Rg5, the ginsenoside CK and the ginsenoside Rg3 are used as auxiliary materials. The ginsenoside nano-micelle is prepared in an intermolecular self-assembly mode, the water solubility and stability of ginsenoside are remarkably improved, the ginsenoside can be uniformly dispersed in a water solution and is not prone to precipitation and degradation, meanwhile, the skin permeability of the ginsenoside can be effectively improved through the nanoscale micelle structure, and the skin permeability of the ginsenoside can be effectively improved. Therefore, the skin care effect of the ginsenoside is fully exerted, and the ginsenoside is very suitable for being applied to skin care products.
Owner:GUANG ZHOU GUANG YA XIN HAN FANG HUA ZHUANG PIN KE JI YOU XIAN GONG SI

Method for synthesizing ginsenoside in tomatoes

The invention belongs to the technical field of saponin synthesis, and particularly relates to a method for synthesizing ginsenoside in tomatoes. The invention aims to provide a new choice for synthesizing ginsenoside. According to the technical scheme, the method for synthesizing the ginsenoside in the tomato is realized by increasing the expression quantity of genes PnSE, PnDS, CYP716A47 and GT95 in the tomato. According to the invention, the PnSE / PnDS / CYP450A47 / GT95 gene of panax notoginseng is co-overexpressed in the plant chassis tomato for the first time, heterologous synthesis of ginsenoside CK in plants is realized, and a new way is provided for extraction of ginsenoside CK.
Owner:CHONGQING UNIV +1

Sna&beta-G (at) Cu / Fe-TADS biological composite material with graded holes and preparation method and application of Sna&beta-G (at) Cu / Fe-TADS biological composite material

PendingCN118956856AEncapsulation in situgood biocompatibilityOn/in organic carrierFermentationDisodium terephthalateBiology
The invention belongs to the field of biological composite materials, and particularly relates to Snaamp with graded holes. The invention discloses a beta-G (at) Cu / Fe-TADS biological composite material and a preparation method and application thereof, and the preparation method comprises the following steps: selecting an organic ligand disodium terephthalate with good water solubility, introducing ferrous ions, and preparing Snaamp containing hierarchical pores through a metal competition strategy; the beta-G (at) Cu / Fe-TADS is used for cascade catalysis of ginsenoside Rb1 to prepare rare ginsenoside CK, graded pore channels can promote mass transfer of a substrate and a product, and large pore channels are beneficial to effective exposure of other pore channels, so that effective contact between enzyme and the substrate is increased, and the catalytic conversion effect of the enzyme is played to the greatest extent. The Snaamp is effectively compensated; in the amplification preparation process of the beta-G coated H-Cu-BDC biological composite material, the problem of hollow cavity disappearance caused by mass transfer is solved.
Owner:XI'AN POLYTECHNIC UNIVERSITY

Antidepressant composition comprising rare ginsenoside and method of preparing the same

The present patent application discloses an antidepressant composition containing rare ginsenosides and a preparation method thereof. The antidepressant composition of the present application contains ginseng hydrolysate, Zizyphus jujuba powder and gamma-aminobutyric acid and other functional ingredients, wherein the ginseng hydrolysate is rich in rare ginsenoside CK. The antidepressant composition of the present application has good antidepressant efficacy, can significantly increase the content of 5-hydroxytryptophan (5-HT) and gamma-aminobutyric acid (GABA) in brain tissue, achieve better enhancement of emotional stability and cognitive flexibility, improve anhedonia, relieve anxiety comorbidity and sleep disorders, provide a steady-state foundation for emotional recovery, and improve the efficacy of antidepressants. At the same time, the antidepressant composition of the present application has no side effects on the human body, the product has high safety, the preparation method is simple, the quality is controllable, and the industrialized continuous production can be realized.
Owner:XIAN GIANT BIOGENE TECH CO LTD +1

Anti-wrinkle composition, application thereof and cosmetic

The invention relates to an anti-wrinkle composition, application thereof and cosmetics, the anti-wrinkle composition comprises ginsenoside CK and low-molecular-weight sodium hyaluronate, the mass ratio of the ginsenoside CK to the low-molecular-weight sodium hyaluronate is 1: (5-100), and the molecular weight of the low-molecular-weight sodium hyaluronate does not exceed 5000 Daltons. The anti-wrinkle composition has the beneficial effects that the usage amount of Ectoine and rare ginsenoside CK can be reduced, so that the cost is saved, and meanwhile, an excellent anti-wrinkle effect is realized.
Owner:SHANGHAI HUARUI WANMEI BIOTECHNOLOGY CO LTD +1

Stimulation-reducing and anti-aging retinoid composition and application thereof

The invention discloses a retinoid composition capable of reducing irritation and resisting aging and application thereof, and belongs to the technical field of preparations for dressing and makeup. The irritation-reducing and anti-aging retinoid composition comprises an anti-aging component and ginsenoside CK, the anti-aging component comprises at least one of retinol and a retinol derivative, and the mass ratio of the anti-aging component to the ginsenoside CK is 1: (0.001-2). The retinoid composition disclosed by the invention has the effects of being small in irritation and synergistically promoting aging resistance. According to the invention, the verbascos exosome is further compounded with a retinoid composition, and the retinoid composition enters the exosome through ultrasonic treatment and incubation so as to enable vesicles to wrap the composition, so that the activity of the composition can be protected, the irritation is further reduced, and the anti-aging effect is improved. Therefore, the retinoid composition provided by the invention is suitable for daily cosmetics.
Owner:GUANG ZHOU GUANG YA XIN HAN FANG HUA ZHUANG PIN KE JI YOU XIAN GONG SI +1

Carboxymethyl chitosan nano freeze-dried powder as well as preparation method and application thereof

The invention discloses carboxymethyl chitosan nano freeze-dried powder as well as a preparation method and application thereof, and belongs to the technical field of nano medicines. The preparation method of the carboxymethyl chitosan nano freeze-dried powder comprises the following steps: dissolving a carboxymethyl chitosan deoxycholic acid polymer with an alcohol solvent, adding the dissolved carboxymethyl chitosan deoxycholic acid polymer into water to prepare a turbid liquid, and carrying out first dialysis to obtain a carboxymethyl chitosan deoxycholic acid nano particle solution; adding ginsenoside CK powder into the solution, stirring at room temperature to enable ginsenoside CK to be loaded on the nanoparticles, and performing second dialysis with water after stirring to obtain a ginsenoside CK carboxymethyl chitosan-deoxycholic acid nanoparticle suspension; and then freeze-drying to obtain the carboxymethyl chitosan nano freeze-dried powder. The prepared carboxymethyl chitosan nano freeze-dried powder has controllable particle size and high drug loading capacity, can specifically release drugs in a tumor slightly acidic environment, remarkably improves the liver cancer treatment effect and biological safety, and has great market application potential.
Owner:XI'AN POLYTECHNIC UNIVERSITY

Mycochlea rubra and application thereof

ActiveCN118995430AStrong beta-glucosidase production potentialGood conversion effectFungiMicroorganism based processesBiotechnologyGinsenoside CK
The invention relates to the technical field of microorganisms, and discloses a strain of phymatopsis tinea and application thereof. According to the invention, the phymatopsis tinctoria is extracted from tuckahoe planting rotten wood for the first time, and it is found that the phymatopsis tinctoria can be used for producing beta-glucosidase. The further research also finds that the beta-glucosidase produced by the strain also has the capability of converting rare ginsenosides CK and Rh1, and can be used for the production of rare ginsenosides and the development of downstream products, so that the beta-glucosidase has wide application prospects and extremely high application values.
Owner:云南悦芳季生物科技有限公司

Application of Ginsenoside C-K in preparation of gram bacterium infection resisting medicine

The invention provides an application of Ginsenoside C-K in preparation of a medicine for resisting gram bacterial infection, and the CAS number of the Ginsenoside C-K is 39262-14-1, the CAS number of the Ginsenoside C-K is 39262-14-1, and the CAS number of the Ginsenoside C-K is 39262-14-1. The Ginsenoside C-K is used for preparing a medicine for resisting gram-positive bacterium infection, and the Ginsenoside C-K and a polypeptide antibiotic polymyxin B are combined to be used for preparing a medicine for resisting gram-negative bacterium infection. According to the technical scheme, the novel medical application of the Ginsenoside C-K. The Ginsenoside C-K has the effects of inhibiting growth of gram-positive bacteria and formation of a biofilm, and the Ginsenoside C-K and polypeptide antibiotic polymyxin B are combined to have the effect of reversing drug resistance of gram-negative bacteria to the polymyxin B. The invention further discloses a preparation method of the Ginsenoside C-K.
Owner:SHENZHEN NANSHAN DISTRICT PEOPLES HOSPITAL

Glucosidase truncated mutant with improved thermal activity and pH adaptability as well as construction method and application of glucosidase truncated mutant

The invention relates to the technical field of gene engineering. The invention provides a glucosidase truncated mutant with improved thermal activity and pH adaptability. The amino acid sequence of the mutant is as shown in SEQ ID NO. 1. On the basis of a homologous modeling method, specific amino acid is truncated to optimize a glucosidase structure, the thermal activity and pH adaptability are improved, the optimum temperature is increased by 10 DEG C, and gt is reserved under the condition that the pH is 5.0; the activity is 50%, and the affinity of a substrate is improved (Km is equal to 0.8517 mM). The invention further provides application of the mutant in preparation of rare ginsenoside CK. The high-titer yield of the rare ginsenoside CK prepared from the mutant is remarkably increased compared with that of the rare ginsenoside CK prepared from a wild enzyme. The preparation process is simple and has the potential of being applied to large-scale industrial production.
Owner:BEIJING UNIV OF CHEM TECH +1

Beta-cyclodextrin-carboxymethyl chitosan-deoxycholic acid nanoparticles loaded with ginsenoside ck, preparation method and application thereof

ActiveCN120983650BBreaking through the bottleneck of limited bioavailabilityHigh drug loading efficiencyOrganic active ingredientsPharmaceutical non-active ingredientsGinsenoside CKPolymer science
The present application relates to the technical field of nanomedicine, in particular to a β-cyclodextrin-carboxymethyl chitosan-deoxycholic acid nanoparticle carrying ginsenoside CK, a preparation method and application. A first esterification reaction is performed between a β-cyclodextrin solution and a carboxyl-activated carboxymethyl chitosan solution to obtain a β-cyclodextrin-carboxymethyl chitosan polymer; a second esterification or amidation reaction is performed by adding carboxyl-activated deoxycholic acid to the β-cyclodextrin-carboxymethyl chitosan polymer to obtain a β-cyclodextrin-carboxymethyl chitosan-deoxycholic acid polymer; an ethanol solution of ginsenoside CK is mixed with a water solution of the β-cyclodextrin-carboxymethyl chitosan-deoxycholic acid polymer to obtain a whole particle, and a freeze-drying protective agent is added for freeze-drying to obtain the β-cyclodextrin-carboxymethyl chitosan-deoxycholic acid nanoparticle carrying ginsenoside CK. The present application focuses on the design of an intelligent carrier, realizes the synergistic optimization of high drug loading and intelligent delivery, and overcomes the defects of the prior art.
Owner:XI'AN POLYTECHNIC UNIVERSITY

A beta-glucosidase and methods of making and using the same

PendingCN122503415ANucleotideBinding site
This invention discloses a β-glucosidase, its preparation method, and its applications, relating to the field of genetic engineering technology. The amino acid sequence of the β-glucosidase is shown in SEQ ID NO:1. The nucleotide sequence encoding this enzyme, optimized for codon bias in *E. coli*, is shown in SEQ ID NO:2. The constructed recombinant expression vector contains an IPTG inducible promoter, a ribosome binding site, a 6×His tag, a TEV protease recognition site, a flexible linker peptide, and the sequence shown in SEQ ID NO:2. The recombinant expression vector is transformed into *E. coli*, and after induction expression, high-density fermentation, and affinity purification, a highly soluble and active target enzyme is obtained. This enzyme can efficiently catalyze the conversion of ginsenoside Rb1 to rare ginsenoside CK, with a conversion rate exceeding 82%. This invention improves the soluble expression level and preparation efficiency of the target enzyme, making it suitable for industrial production.
Owner:XIAN INT UNIV

Preparation method and application of ginseng leavening for improving content of converted ginsenoside CK

The invention relates to the technical field of fermentation engineering, and particularly discloses a preparation method and application of a ginseng leavening for improving the content of transformed ginsenoside CK. The preparation method comprises the following fermentation conditions: 1) performing carbon source and nitrogen source combined regulation on ginseng root hair fermentation liquor; (2) inoculating the three probiotics into the ginseng root hair fermentation liquor in stages, and carrying out synergistic fermentation; 3) regulating and controlling the dissolved oxygen level in stages; 4) regulating and controlling fermentation conditions by stages; the carbon source comprises fructo-oligosaccharide, inulin and xylooligosaccharide; the nitrogen source comprises soybean protein isolate and pea protein; the probiotics comprise strains of the genus Lactobacillus, the genus Bifidobacterium and the genus Saccharomyces. According to the method, the yield of ginsenoside CK in the ginseng leavening can be remarkably increased, the fermentation efficiency is improved, and the fermentation period is shortened.
Owner:ZHONG KE YAO CHUANG (QING DAO) FA JIAO GONG CHENG YOU XIAN GONG SI

A beta-glucosidase lyophilization protectant and its use in the production of CK

The present application relates to the technical field of bioengineering, and particularly relates to a beta-glucosidase freeze-drying protective agent and application thereof in production of CK. The present application utilizes beta-glucosidase Bgp3 to prepare rare ginsenoside CK, adopts a freeze-drying technology to prepare a freeze-dried powder from Bgp3 protein supernatant, and adds a specific freeze-drying protective agent before freeze-drying, so as to protect the enzyme activity, improve the enzyme stability, and facilitate storage and longer preservation time. The present application adds a freeze-drying protective agent with a combination of trehalose, arginine and mannitol as raw materials, and the Bgp3 freeze-dried powder prepared without the protective agent has high catalytic efficiency. The present application provides a method for producing rare ginsenoside CK by utilizing beta-glucosidase Bgp3, which has high bioconversion rate, mild reaction conditions, simple equipment and easy operation, and provides technical support for industrial production of rare ginsenoside CK.
Owner:GUANGZHOU QINGNANG BIOTECHNOLOGY CO LTD +1

Gynostemma pentaphyllum glycosyl transferase GpUGT74A1 and application thereof

PendingCN119331848Ahigh homologysimple methodBacteriaTransferasesProtopanaxadiolAmino acid
The invention discloses a gynostemma pentaphyllum glycosyl transferase GpUGT74A1 and application thereof, and relates to the technical field of biology, and the amino acid sequence of the gynostemma pentaphyllum glycosyl transferase GpUGT74A1 is as shown in SEQ ID NO.3. The gynostemma pentaphyllum glycosyl transferase GpUGT74A1 has the advantages that the gynostemma The invention provides a brand-new gynostemma pentaphyllum glycosyl transferase, and the gynostemma pentaphyllum glycosyl transferase catalyzes the 20th hydroxyl of protopanaxatriol PPT and protopanoxadiol PPD to form glycosidic bonds with glucose molecules, so that ginsenoside F1 and ginsenoside CK are respectively generated. Compared with a plurality of known gynostemma pentaphyllum glycosyl transferases, the gynostemma pentaphyllum glycosyl transferases have the highest homology of UGTGp5, and the homology is 36.32%. When the gynostemma pentaphyllum glycosyl transferase is used for preparing ginsenoside F1 and ginsenoside CK, the method and the process are simple, the yield is high, and the consumption is low. The current glycosyl transferase database is enriched.
Owner:FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE

Composition with weight loss efficacy and use thereof

PendingCN122351422AFucoxanthinAmylase inhibitors
Compositions with weight-loss effects and their applications belong to the field of biomedicine. To improve the fat-reducing effect and further solve the off-target effect problem caused by existing weight-loss mechanisms, the composition includes fucoxanthin 0.8%~2.5%, ginsenoside CK 0.6%~1.2%, black ginseng active peptide 0.3%~0.6%, amylase inhibitor 12%~30%, prickly pear cactus extract 6%~15%, allicin 0.2%~0.6%, and excipients. This invention achieves weight regulation through comprehensive synergy of multiple targets.
Owner:DALIAN SHENLAN PEPTIDE TECH R & D CO LTD

Bacillus safensis Sys-Gs-001 strain for producing ginsenoside CK and application of bacillus safensis Sys-Gs-001 strain

The invention provides a bacillus safensis Sys-Gs-001 strain for producing ginsenoside CK, the strain is preserved in the China Center for Type Culture Collection on November 24, 2025, the preservation number is CCTCC NO: M20252681, the preservation number is CCTCC NO: M20252681, the preservation number is CCTCC NO: M20252681, and the preservation number is CCTCC NO: M20252681. The 16S rDNA (ribosomal deoxyribonucleic acid) sequence of the strain is as shown in SEQ ID NO. 1. The bacillus safensis Sys-Gs-001 strain provided by the invention can produce ginsenoside CK through metabolism, can be subjected to large-scale fermentation culture in a short time, is relatively low in fermentation cost, is not limited by conditions such as time domains and seasons, and has remarkable advantages. Meanwhile, the invention also provides optimized microbial fermentation conditions and a formula of the culture medium, and the yield of the ginsenoside CK is relatively high.
Owner:SHUIMU SHENGYUAN (BEIJING) TECHNOLOGY CO LTD

Ginsenoside CK-aescin supramolecule and preparation method thereof

The invention relates to the technical field of supramolecules, in particular to a ginsenoside CK-aescin supramolecule, in the supramolecule, ginsenoside CK and aescin are formed through a non-covalent bond, the mass ratio of ginsenoside CK to aescin is 1: (1-25), and a preparation method comprises the following steps: dispersing aescin in an organic solvent aqueous solution to prepare a suspension A, dissolving ginsenoside CK in ethanol to prepare a solution D for later use; stirring the suspension A to obtain a suspension B; performing ultrasonic treatment on the suspension B to obtain emulsion C; slowly adding the emulsion C into the solution D while stirring, stirring to obtain a ginsenoside CK-aescin supramolecular solution crude product, and dialyzing. According to the ginsenoside CK-aescin supramolecule prepared by the invention, an IVPT test shows that the transdermal absorption capacity of the ginsenoside CK-aescin supramolecule is remarkably improved, so that the ginsenoside CK-aescin supramolecule can be better absorbed by human skin, and the efficacy of the ginsenoside CK-aescin supramolecule is favorably exerted.
Owner:CHANGZHOU FUQIAN BIOTECHNOLOGY CO LTD

Application of ginsenoside CK in treatment of insomnia

The invention discloses application of ginsenoside CK or salt thereof in preparation of drugs, food and / or health care products for preventing and / or treating insomnia. Ginsenoside CK shows the most significant anti-inflammatory and insomnia-improving effects in vitro and in vivo.
Owner:SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M

A rare ginsenoside efficacy composition and a preparation method thereof

This patent application discloses a rare ginsenoside functional composition and its preparation method. The rare ginsenoside functional composition of this invention comprises active ingredients such as ginseng enzymatic hydrolysate and ginseng fermentation product, wherein the ginseng enzymatic hydrolysate is rich in rare ginsenoside CK, and the ginseng fermentation product is rich in ginsenosides Rk1, Rg5, Rk3, and Rh4. The rare ginsenoside functional composition of this invention has good effects in relieving mental stress and antidepressant effects.
Owner:XIAN GIANT BIOGENE TECH CO LTD +1

An enzyme composition for producing rare ginsenosides and its application

The present application relates to the field of medical technology, and specifically discloses an enzyme composition for generating rare ginsenosides and its application. The enzyme composition includes pectin methylesterase and β-glycosidase; the mass ratio of the pectin methylesterase and β-glycosidase is 1: (0.2~2). The present application adopts pectin methylesterase and β-glycosidase to cooperate with each other, which can efficiently convert ginseng stem and leaf extract or ginsenoside Rb1 into rare ginsenoside CK, with high conversion efficiency, low cost, simple operation and environmental protection. And the rare ginsenosides obtained by the enzymatic hydrolysis method have the advantages of high selectivity, mild reaction conditions, high conversion rate, easy separation and purification, no pollution to the environment and low cost. The rare ginsenosides generated by the enzyme composition of the present application show stronger skin repair effects, can be better used in skin care products, and have good application prospects.
Owner:宝萃生物科技有限公司

Rhizoma panacis majoris glycosyl transferase PjvmUGT45 as well as mutant and application thereof

The invention relates to rhizoma panacis majoris glycosyl transferase PjvmUGT45 as well as a mutant and application thereof. The amino acid sequence of the glycosyl transferase PjvmUGT45 is as shown in SEQ ID NO. 2; the amino acid sequence of the mutant is as shown in SEQ ID NO. 4 or SEQ ID NO. 6. The protein and the mutant thereof can catalyze and generate rare ginsenosides F2 and Rh2 by taking ginsenosides CK and PPD as substrates, belong to glycosyltransferase, have the catalytic efficiency obviously superior to that of two known glycosyltransferase UGTPg45 and PgUGT74AE2 with the same catalytic function in ginseng, can be used for in-vitro catalytic synthesis of the rare ginsenosides F2 and Rh2, and have the advantages of high yield, high yield and the like. Particularly, the catalytic efficiency of the mutant with the amino acid sequence shown as SEQ ID NO.4 is superior to that of wild type glycosyl transferase PjvmUGT45.
Owner:WUHAN POLYTECHNIC UNIVERSITY